Home
Education
Real Estate
Finance
Health
Travel
Dating
Classifieds
TRI-STATE RUSSIAN MEDIA GROUP:
Health Expert of the Month
Quality Affordable Dental Coverage
News
Lifestyle
Law
Insurance
Automotive
Employment
Advertise

EurekAlert! - Medicine and Health

02/20/2020 12:00 AM
For 'blade runners' taller doesn't necessarily mean faster
(University of Colorado at Boulder) The governing body for the Paralympics recently lowered the allowable height for sprinters who use prosthetic legs, or blades, during competition. The rules are based on the assumption that the taller you are the faster you run. But a new study has found otherwise.

02/20/2020 12:00 AM
Researchers develop label-free microscopic techniques to visualize extracellular vesicles
(Beckman Institute for Advanced Science and Technology) The Biophotonics Imaging Lab at the Beckman Institute, led by Dr. Stephen Boppart, has recently published papers in the Proceedings of the National Academy of Sciences and in Precision Oncology that use label-free microscopic techniques to visualize extracellular vesicles, which are associated with cancer.

02/20/2020 12:00 AM
Delivering bad news: 'Patients remember these conversations forever'
(Northwestern University) Despite known protocols and recommendations on how to break bad news to patients, many physicians report insufficient training about how to conduct these challenging conversations. Northwestern University Feinberg School of Medicine has found a better way, according to a newly published study. A new class offered to Feinberg medical students uses an approach called 'simulation-based mastery learning' to train physicians to have difficult conversations with patients in a clear and compassionate way.

02/20/2020 12:00 AM
Huntsman Cancer Institute to host 7th Annual Metastatic Breast Cancer Research Conference
(Huntsman Cancer Institute) The 7th annual Metastatic Breast Cancer Research Conference will be hosted by Huntsman Cancer Institute (HCI) at the University of Utah (U of U) in partnership with Baylor College of Medicine and Theresa's Research Foundation on September 10 and 11, 2020.

02/20/2020 12:00 AM
The fat around your arteries may actually keep them healthy
(Michigan State University) A Michigan State University researcher is adding new evidence to the argument that the fat around our arteries may play an important role in keeping those blood vessels healthy. The finding could affect how researchers test for treatments related to plaque buildup in our arteries, or atherosclerosis, an issue that can often lead to a heart attack, which is currently a leading cause of death in the United States.

02/20/2020 12:00 AM
MD Anderson announces strategic collaboration with Denali Therapeutics to research and develop targeted therapies for neurodegenerative diseases
(University of Texas M. D. Anderson Cancer Center) MD Anderson announces a strategic research collaboration with Denali Therapeutics to develop new targeted therapies for Alzheimer's and other neurodegenerative diseases.

02/20/2020 12:00 AM
Columbia University researchers awarded $2M to identify antiviral drugs for coronavirus
(Columbia University Irving Medical Center) Four research teams at Columbia University will share a $2.1 million grant to mount an aggressive effort to identify potential antiviral drugs and antibodies for use against the new coronavirus, 2019-nCoV.

02/20/2020 12:00 AM
Research shows new drug helps to preserve brain cells for a time after stroke
(University of Calgary) After 50 years of research and the testing of over 1,000 drugs, there is new hope for preserving brain cells for a time after stroke. Treating acute ischemic stroke patients with an experimental neuroprotective drug, combined with a surgical procedure to remove the clot improves outcomes as shown by clinical trial results published today in The Lancet.

02/20/2020 12:00 AM
Lower dose of newer clot-buster may be appropriate for some stroke patients
(American Heart Association) In a comparison of 0.25mg/kg and 0.40mg/kg doses of the newer and more convenient clot-busting medication tenecteplase, there was no advantage in increasing the dose above 0.25mg/kg in stroke patients who planned to have mechanical clot retrieval.In addition, administering tenecteplase may decrease the need for mechanical clot removal.

02/20/2020 12:00 AM
Wearable brain stimulation could safely improve motor function after stroke
(American Heart Association) A new, non-invasive wearable magnetic device that stimulates the brain to rewire itself is safe and could improve recovery for stroke survivors. The technology could be a step to help improve motor function after stroke.

02/20/2020 12:00 AM
Follow-up study suggests brain stents are safe and effective for reducing recurrent stroke risk
(American Heart Association) Placing stents in cholesterol-clogged brain arteries may be an option to reduce the risk of a repeat stroke.However, it is too soon to know if stenting in the brain arteries improves long-term patient outcomes.

02/20/2020 12:00 AM
Fast treatment via mobile stroke unit reduced survivor disability
(American Heart Association) Stroke patients were more likely to get clot-busting treatment and received it faster if treatment started in a mobile stroke unit, an ambulance specially equipped to provide treatment.Those treated in a mobile stroke unit had less post-stroke disability, a German study found.

02/20/2020 12:00 AM
Bundled payments have not led to 'cherry-picking' of patients for joint replacement surgery
(Wolters Kluwer Health) A pilot program introducing bundled payments for hip and knee replacement (HKR) in Medicare patients hasn't led hospitals to 'cherry-pick' healthier patients at lower risk of complications, reports a study in the February 19, 2020 issue of The Journal of Bone & Joint Surgery. The journal is published in the Lippincott portfolio in partnership with Wolters Kluwer.

02/20/2020 12:00 AM
Clinical trial exposes deadly kidney cancer's Achilles' heel
(UT Southwestern Medical Center) An experimental drug already shown to be safe and help some patients with clear cell renal cell carcinoma, a deadly form of kidney cancer, effectively disables its molecular target.

02/20/2020 12:00 AM
Study shows UV technology raises the standard in disinfecting ORs and medical equipment
(Northwell Health) Ultraviolet (UV) technology developed by the New York-based firm PurpleSun Inc. eliminates more than 96 percent of pathogens in operating rooms (ORs) and on medical equipment, compared to 38 percent using manual cleaning methods that rely on chemicals to disinfect surfaces, according to a study published this month in the American Journal of Infection Control (AJIC).

02/20/2020 12:00 AM
Therapeutic cooling effectively targets site of brain injury
(Children's Hospital Los Angeles) Investigators successfully measure brain temperature in newborn babies undergoing therapeutic cooling, showing that the treatment effectively targets the core of the brain.

02/20/2020 12:00 AM
The University of Tennessee System announces One Health Initiative
(University of Tennessee Institute of Agriculture) The University of Tennessee System has announced the creation of the UT One Health Initiative (UTOHI), an effort to enhance research collaborations across the state and region to address rapidly emerging health challenges. The UTOHI will focus on animal and environmental health issues of particular relevance to Tennessee that may also have broad implications regionally, nationally and globally.

02/20/2020 12:00 AM
About 8% of West Virginia babies are exposed to alcohol shortly before birth
(West Virginia University) About 8 percent of West Virginia newborns are exposed to alcohol two to four weeks before birth, according to a new study.

02/20/2020 12:00 AM
Condom nation
(McMaster University) Researchers at McMaster University have peered into the most intimate moments of sexually active women and men across Canada to ask if they're using condoms, all in an effort to gather data that could inform decisions around public health and sex education.

02/20/2020 12:00 AM
Study shows long-term survival benefit for certain patients with advanced lung cancer
(Yale University) According to the results of a large, global study led by Yale Cancer Center researchers, even a tiny amount of a biomarker known as PD-L1 (programmed death-ligand1) can predict a long-term survival benefit from using pembrolizumab (Keytruda).

02/20/2020 12:00 AM
Patients most at risk of overdose at the beginning and after end of methadone treatment
(RCSI) A new study, led by RCSI researchers, has found that patients receiving methadone treatment are most at risk of overdosing in the month following the end of methadone treatment and during the first four weeks of treatment.

02/20/2020 12:00 AM
New drug combination restores beta cell function in animal model
(Helmholtz Zentrum München - German Research Center for Environmental Health) In a new study in mice, Helmholtz Zentrum München in collaboration with Novo Nordisk, demonstrated for the first time that a targeted combinatorial drug treatment is able to restore beta cell function, achieve beta cell redifferentiation and therefore potentially open new ways for diabetes remission.

02/20/2020 12:00 AM
E-cigarette users are exposed to potentially harmful levels of metal linked to DNA damage
(University of California - Riverside) Researchers at the University of California, Riverside, have completed a cross-sectional human study that compares biomarkers and metal concentrations in the urine of e-cigarette users, nonsmokers, and cigarette smokers. They found that the biomarkers, which reflect exposure, effect, and potential harm, are both elevated in e-cigarette users compared to the other groups and linked to metal exposure and oxidative DNA damage.

02/20/2020 12:00 AM
Active droplets
(Technical University of Munich (TUM)) Using a mixture of oil droplets and hydrogel, medical active agents can be not only precisely dosed, but also continuously administered over periods of up to several days. The active agents inside the droplets are released at a constant rate, decreasing the risk of over- or underdosage.

02/20/2020 12:00 AM
Hispanics/Latinos underrepresented in Alzheimer's disease research
(University of Houston) The largest ethnic minority in the US, at 18% of the population, Hispanics/Latinos are 50% more likely to develop Alzheimer's disease than non-Hispanic whites, yet they comprise less than 1% of clinical trials for Alzheimer's. A University of Houston researcher is set on changing that, by increasing health literacy among Hispanics/Latinos and closing the health disparity gap.

powered by EurekAlert! - Medicine and Health
The premier online source for science news since 1996. A service of the American Association for the Advancement of Science.

Dentistry

Dentistry

Medical Doctor

Copyright © Russian Market 2003. All rights reserved. Disclaimer